Skip to main content
. 2021 Jul 14;40(23):5096–5114. doi: 10.1002/sim.9113

TABLE 2.

Proportions of selecting each dose regimen Sk as the MTD‐regimen over the 1000 trials in the six main toxicity scenarios. For each scenario, the marginal probabilities of dose limiting toxicity (DLT), cytokine release syndrome (CRS), and other DLT (DLTo) are defined, and the association between the CRS and DLTo is represented by the average risk ratio (RR). Results are presented for the three joint approaches (DRtox_indep, DRtox_copula, and DRtox_cond) and the continual reassessment method (CRM). The proportions of correct selection (PCS) of the MTD‐regimen are represented in bold

Scenario Set RR Method
S1
S2
S3
S4
S5
S6
1 A 1.85
pT
0.10 0.14 0.18 0.30 0.45 0.60
pT(1)
0.05 0.07 0.1 0.18 0.22 0.30
pT(2)
0.06 0.08 0.1 0.17 0.34 0.50
DRtox_indep 0 4 24 55 16 2
DRtox_copula 0 2 20 55 20 3
DRtox_cond 0 3 25 55 16 2
Logistic CRM 0 4 22 46 22 5
2 A 5.91
pT
0.10 0.13 0.18 0.30 0.42 0.53
pT(1)
0.07 0.10 0.13 0.22 0.28 0.36
pT(2)
0.04 0.07 0.10 0.21 0.39 0.52
DRtox_indep 0 4 27 48 16 3
DRtox_copula 0 3 17 52 24 5
DRtox_cond 0 3 23 52 18 4
Logistic CRM 0 4 18 42 26 10
3 A 1.81
pT
0.11 0.15 0.18 0.30 0.45 0.59
pT(1)
0.03 0.05 0.07 0.13 0.16 0.23
pT(2)
0.08 0.11 0.13 0.22 0.39 0.54
DRtox_indep 1 3 22 57 15 2
DRtox_copula 1 2 16 58 20 2
DRtox_cond 1 3 22 58 15 2
Logistic CRM 1 5 22 48 19 5
4 A 1.90
pT
0.09 0.13 0.17 0.30 0.44 0.59
pT(1)
0.07 0.10 0.13 0.23 0.29 0.37
pT(2)
0.03 0.04 0.06 0.12 0.27 0.43
DRtox_indep 0 3 24 56 14 2
DRtox_copula 0 2 19 56 20 4
DRtox_cond 0 3 24 55 15 2
Logistic CRM 0 4 20 46 23 7
5 A 1.97
pT
0.03 0.04 0.05 0.11 0.17 0.30
pT(1)
0.02 0.03 0.05 0.09 0.11 0.17
pT(2)
0.00 0.01 0.01 0.02 0.08 0.18
DRtox_indep 0 0 0 4 29 67
DRtox_copula 0 0 0 3 20 77
DRtox_cond 0 0 0 4 29 67
Logistic CRM 0 0 0 2 21 77
6 B 1.70
pT
0.16 0.30 0.43 0.55 0.73 0.86
pT(1)
0.09 0.17 0.25 0.33 0.38 0.48
pT(2)
0.08 0.18 0.29 0.41 0.67 0.84
DRtox_indep 20 64 15 1 0 0
DRtox_copula 14 63 21 2 0 0
DRtox_cond 19 65 15 1 0 0
Logistic CRM 17 56 24 3 0 0